Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel

Raymakers Adam J. N.; Regier Dean A.; Peacock Stuart J.

首页> 外文期刊>Health policy and technology. >Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel

【24h】

Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel

机译：在生存期和成本效益中建模不确定性在基因治疗时代至关重要：AxicabTagene CileOlewel的情况

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Health policy and technology.》 |2019年第2期|共2页
作者
Raymakers Adam J. N.; Regier Dean A.; Peacock Stuart J.;
展开▼
作者单位

BC Canc Vancouver BC Canada;

BC Canc Vancouver BC Canada;

BC Canc Vancouver BC Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel [J] . Raymakers Adam J. N., Regier Dean A., Peacock Stuart J. Health policy and technology. . 2019,第2期

机译：在生存期和成本效益中建模不确定性在基因治疗时代至关重要：AxicabTagene CileOlewel的情况
2. Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma [J] . Sim Austin J., Jain Michael D., Figura Nicholas B., International Journal of Radiation Oncology, Biology, Physics . 2019,第5期

机译：放射疗法作为汽车T细胞疗法的桥接策略，XICRABTAGE CILOLEUREL在弥漫性大B细胞淋巴瘤中
3. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [J] . Andreas Viardot, Verena Wais, Elisa Sala, Cancer Management and Research . 2019,第4期

机译：嵌合抗原受体（轿车）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：视角于轴突的腋生虫蛋白的治疗潜力
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. A Markov model simulation of neurodegenerative Parkinson's disease and cost-effectiveness analysis of pharmacotherapy and deep brain stimulation treatment [D] . Quock, Tiffany Puisanne 2008

机译：神经变性帕金森氏病的马尔可夫模型模拟以及药物治疗和深部脑刺激治疗的成本效益分析
6. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [O] . Andreas Viardot, Verena Wais, Elisa Sala, 2019

机译：嵌合抗原受体（CAR）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：Axicabtagene ciloleucel的治疗潜力的观点
7. Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy [O] . Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, 2020

机译：在用不同的CD19导向汽车T细胞疗法之前治疗后复发或难治性淋巴瘤的AxicaBTAGENTAGENILOLEURETEL

Modelling uncertainty in survival and cost-effectiveness is vital in the era of gene therapies: the case of axicabtagene ciloleucel

著录项

相似文献

相关主题

期刊订阅